The kinetics of a memory B cell response to virus like particles in mice

The kinetics of a memory B cell response to virus like particles in mice

Opis bibliograficzny
Główni autorzy:	Zabel, F, Mohanan, D, Link, A, Bessa, J, Saudan, P, Kuendig, T, Bachmann, M
Format:	Journal article
Wydane:	2012

Podobne zapisy

Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies
od: Zabel, F, i wsp.
Wydane: (2014)

Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies.
od: Zabel, F, i wsp.
Wydane: (2014)

Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses.
od: Bessa, J, i wsp.
Wydane: (2012)

Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
od: Gomes, A, i wsp.
Wydane: (2017)

Bacterially produced recombinant influenza vaccines based on virus-like particles
od: Jegerlehner, A, i wsp.
Wydane: (2013)

Bacterially produced recombinant influenza vaccines based on virus-like particles.
od: Andrea Jegerlehner, i wsp.
Wydane: (2013-01-01)

B cell TLRs and the antibody response to virus particles
od: DeFranco, A, i wsp.
Wydane: (2011)

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
od: Jegerlehner, A, i wsp.
Wydane: (2010)

Versatile virus-like particle carrier for epitope based vaccines
od: Tissot, A, i wsp.
Wydane: (2010)

Virus-induced humoral immunity: on how B cell responses are initiated.
od: Zabel, F, i wsp.
Wydane: (2013)

Virus-induced humoral immunity: On how B cell responses are initiated
od: Zabel, F, i wsp.
Wydane: (2013)

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
od: Bessa, J, i wsp.
Wydane: (2008)

Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles.
od: Gatto, D, i wsp.
Wydane: (2007)

Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory.
od: Bründler, M, i wsp.
Wydane: (1996)

Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses.
od: Su-Hwa Lee, i wsp.
Wydane: (2019-01-01)

The coming of age of virus-like particle vaccines.
od: Jennings, G, i wsp.
Wydane: (2008)

Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10
od: Manolova, V, i wsp.
Wydane: (2008)

Virus-like particles induce robust human T-helper cell responses.
od: Braun, M, i wsp.
Wydane: (2012)

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.
od: Schmitz, N, i wsp.
Wydane: (2009)

Special Issue “Virus-Like Particle Vaccines”
od: Monique Vogel, i wsp.
Wydane: (2020-08-01)

Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life span.
od: Gatto, D, i wsp.
Wydane: (2007)

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
od: Paul Engeroff, i wsp.
Wydane: (2019-01-01)

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
od: Zhang Quanfu, i wsp.
Wydane: (2011-06-01)

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
od: Dace Skrastina, i wsp.
Wydane: (2014-01-01)

Zika virus like particles elicit protective antibodies in mice.
od: Mauricio A Salvo, i wsp.
Wydane: (2018-02-01)

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases
od: Bachmann, M
Wydane: (2005)

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
od: Storni, T, i wsp.
Wydane: (2002)

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
od: Zeltins, A, i wsp.
Wydane: (2017)

A universal Influenza A vaccine based on M2 mediates complete protection from lethal infection in mice
od: Schmitz, N, i wsp.
Wydane: (2007)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
od: Klimek, L, i wsp.
Wydane: (2014)

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.
od: Hou, B, i wsp.
Wydane: (2011)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
od: Doucet, M, i wsp.
Wydane: (2017)

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses.
od: Bessa, J, i wsp.
Wydane: (2009)

Plant-Produced Antigen Displaying Virus-Like Particles Evokes Potent Antibody Responses against West Nile Virus in Mice
od: Junyun He, i wsp.
Wydane: (2021-01-01)

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
od: Ming Yang, i wsp.
Wydane: (2017-08-01)

Toll-like receptor 7 signaling drives IgA responses
od: Bessa, J, i wsp.
Wydane: (2007)

Virus-like particles as a modular system for novel vaccines.
od: Lechner, F, i wsp.
Wydane: (2002)

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
od: Dominik A. Rothen, i wsp.
Wydane: (2024-09-01)

Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice
od: A. T. M. Badruzzaman, i wsp.
Wydane: (2024-06-01)

Mosquito Cell-Derived Japanese Encephalitis Virus-Like Particles Induce Specific Humoral and Cellular Immune Responses in Mice
od: Yu-Hsiu Chang, i wsp.
Wydane: (2020-03-01)